MiSight 1 Day

DEVICE3 trials

Sponsors

CooperVision, Inc., Pauline Kang

Conditions

MyopiaMyopia Progressing

Unknown Phase

MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms

Active, not recruitingNCT05285553

CooperVision, Inc.Myopia

Start: 2022-06-25End: 2030-06-30Target: 900Updated: 2026-07-08

MiSight 1 Day Safety Post-Approval Study

Active, not recruitingNCT05285527

CooperVision, Inc.Myopia

Start: 2022-08-15End: 2030-06-30Target: 2400Updated: 2026-07-08

Comparison of MiSight 1-Day and Acuvue Oasys for Presbyopia in Myopic Children

Active, not recruitingNCT06887920

Pauline KangMyopia Progressing

Start: 2021-02-11End: 2025-12-31Target: 72Updated: 2025-03-26

Related Papers

MultifocAL COntact Lenses for Myopia (MALCOLM) control in Australian children: a study protocol for a double-blind, contralateral eye, non-inferiority, randomised controlled clinical trial

BMJ Open2025-04-01